V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10380491 | 10068999 | null | 87 | Palliative (P) | 2022-02-11 | 2022-03-25 | Palbociclib | 02 | N | PALBOCICLIB | 100357870 |
| 10380513 | 10069000 | 1.74 | 71 | null | 2016-12-09 | 2017-01-08 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101129962 |
| 10381044 | 10069003 | 1.67 | 80.2 | 03 | null | 2021-06-08 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100273237 |
| 10381113 | 10069004 | 1.89 | 66.2 | Palliative (P) | 2018-08-27 | 2018-09-27 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101216699 |
| 10382031 | 10069007 | null | 84.1 | Neo-adjuvant (N) | 2019-12-28 | 2020-01-08 | DABRAFENIB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101623011 |
| 10382128 | 10069008 | 1.67 | 95 | Palliative (P) | 2018-10-21 | 2018-11-16 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | CISPLATIN | 100329831 |
| 10383005 | 10069009 | 1.78 | 97 | Curative (C) | 2021-03-23 | 2021-04-08 | Palbociclib | 02 | N | PALBOCICLIB | 101551163 |
| 10383158 | 10069012 | 1.7 | 83.5 | Palliative (P) | 2020-03-06 | 2020-03-10 | Carboplatin + Liposomal Doxorubicin | 02 | N | NIRAPARIB | 100700369 |
| 10383758 | 10069015 | 1.69 | 86.25 | Palliative (P) | 2016-11-03 | 2018-03-16 | Azacitidine | 02 | N | AZACITIDINE | 100732005 |
| 10383819 | 10069016 | 1.66 | 68.1 | 03 | 2020-09-03 | 2020-09-14 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100441465 |
| 10384006 | 10069018 | 1.78 | null | null | 2018-01-11 | 2018-01-11 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 99 | null | BORTEZOMIB + THALIDOMIDE | 101054517 |
| 10384319 | 10069020 | 1.75 | 94.2 | null | 2019-11-15 | 2019-12-13 | Melphalan IV High dose | 02 | null | MELPHALAN | 100176167 |
| 10384537 | 10069021 | 1.76 | 67.1 | null | 2021-11-05 | 2021-12-15 | Acalabrutinib | 99 | null | DABRAFENIB | 101390387 |
| 10384939 | 10069023 | 1.75 | 81.4 | null | 2013-01-06 | 2018-01-04 | AFATINIB | 02 | null | AFATINIB | 100235927 |
| 10385524 | 10069025 | 1.57 | 91 | null | 2020-02-03 | 2020-02-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CAPECITABINE + IRINOTECAN | 100116411 |
| 10385774 | 10069026 | 1.75 | 63 | null | 2021-08-12 | 2021-08-23 | CVP R | 02 | null | NIRAPARIB | 101162058 |
| 10386123 | 10069027 | 1.75 | 55.6 | null | 2018-04-30 | 2018-05-02 | Niraparib | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101063711 |
| 10386259 | 10069028 | 1.69 | 81 | Adjuvant (A) | 2020-02-02 | 2020-02-10 | Azacitidine | 02 | N | AZACITIDINE | 100045841 |
| 10386265 | 10069029 | 1.7 | 61.7 | null | 2020-03-16 | 2020-04-30 | Carboplatin + Liposomal Doxorubicin | 02 | null | NIRAPARIB | 101452827 |
| 10386670 | 10069031 | 1.7 | 74.9 | 02 | 2019-05-27 | 2019-05-31 | Cisplatin + Vinorelbine (IV) | 02 | N | CETUXIMAB | 101070837 |
| 10387021 | 10069033 | 1.7 | 75 | Neo-adjuvant (N) | null | 2019-01-21 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100778654 |
| 10387611 | 10069035 | 1.59 | null | null | 2018-10-11 | 2018-10-21 | null | 02 | null | CETUXIMAB | 100167365 |
| 10387807 | 10069036 | 1.8 | 71 | null | 2019-03-13 | 2019-03-13 | Azacitidine | 2 | null | AZACITIDINE | 100494608 |
| 10387965 | 10069037 | 1.7 | 75.5 | Curative (C) | 2020-09-01 | 2021-05-04 | CABOZANTINIB | N | N | NIRAPARIB | 101679067 |
| 10388018 | 10069038 | 1.69 | 98.25 | null | 2016-12-21 | 2019-03-06 | Cabazitaxel | 02 | null | CABAZITAXEL | 101054566 |
| 10388184 | 10069039 | 1.7 | 100.4 | null | 2021-04-03 | 2021-04-10 | Azacitidine | 02 | null | AZACITIDINE | 100641963 |
| 10388212 | 10069040 | 1.55 | 49.5 | 03 | 2021-12-29 | 2021-12-30 | Azacitidine | 02 | N | AZACITIDINE | 100539760 |
| 10388255 | 10069041 | null | 56.7 | 03 | 2022-01-26 | 2022-05-27 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100073944 |
| 10388440 | 10069042 | 1.67 | 99.3 | Palliative (P) | 2019-04-14 | 2020-09-12 | Fluorouricil + Folonic Acid (MdG) | 02 | N | CISPLATIN + GEMCITABINE | 101539323 |
| 10388489 | 10069043 | null | 57.1 | null | 2017-06-02 | 2017-07-31 | BUSULFAN | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100070013 |
| 10388558 | 10069044 | 1.67 | 91.4 | Palliative (P) | 2019-05-08 | 2019-06-03 | FLUOROURACIL | 02 | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100157464 |
| 10388815 | 10069045 | 0 | null | 03 | 2017-12-27 | 2018-01-20 | IPILIMUMAB + NIVOLUMAB | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101530889 |
| 10388828 | 10069046 | 1.61 | 56 | null | 2019-01-21 | 2019-07-26 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100260280 |
| 10389303 | 10069047 | 1.7 | 88 | Palliative (P) | 2019-01-19 | 2019-03-02 | Capecitabine (14 day) + Irinotecan | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101789811 |
| 10390012 | 10069050 | 1.8 | 94.6 | null | 2019-10-05 | 2019-12-01 | AFATINIB | 02 | null | AFATINIB | 101020563 |
| 10390065 | 10069051 | 1.68 | 89.4 | null | 2020-09-11 | 2020-10-16 | Acalabrutinib | 02 | null | CABOZANTINIB | 101295404 |
| 10390163 | 10069052 | 1.74 | 45.8 | 03 | 2019-03-30 | 2019-05-04 | Vinorelbine (oral) | 02 | N | NIRAPARIB | 100682907 |
| 10390535 | 10069054 | 1.62 | 94 | Palliative (P) | 2020-11-22 | 2020-12-04 | AFATINIB | 02 | N | AFATINIB | 100994518 |
| 10390565 | 10069055 | 1.66 | 59 | null | 2018-08-18 | 2018-09-01 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100055524 |
| 10391784 | 10069059 | 1.56 | 0 | Neo-adjuvant (N) | 2020-06-17 | 2020-09-23 | AFATINIB | 02 | Y | AFATINIB | 100995757 |
| 10392325 | 10069061 | 1.76 | 71 | null | 2022-03-31 | 2022-04-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | ACALABRUTINIB | 100748911 |
| 10392347 | 10069062 | 1.7 | 0 | Palliative (P) | 2018-01-04 | 2018-01-21 | Methotrexate intrathecal | 02 | N | METHOTREXATE | 101734816 |
| 10392600 | 10069063 | 1.57 | 124 | Palliative (P) | 2020-03-11 | 2020-03-11 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100781718 |
| 10392729 | 10069065 | 1.59 | 45.7 | null | 2019-03-10 | 2019-03-17 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100025261 |
| 10393729 | 10069066 | 1.66 | 88 | Curative (C) | 2018-10-23 | 2018-10-23 | Carboplatin + Vinorelbine IV &PO D8 | 02 | N | CARBOPLATIN + VINORELBINE | 101140195 |
| 10393798 | 10069067 | 1.72 | 75.8 | null | 2021-06-13 | 2021-06-25 | Cabazitaxel | 02 | null | CABAZITAXEL | 100784295 |
| 10393881 | 10069068 | null | 83 | Palliative (P) | 2018-11-19 | 2018-12-09 | CISPLATIN + VINORELBINE | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101109475 |
| 10394017 | 10069069 | 1.71 | 73.7 | Adjuvant (A) | 2019-12-24 | 2020-04-15 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 100469794 |
| 10394052 | 10069070 | 1.88 | null | Palliative (P) | 2019-02-10 | 2019-02-24 | CVP R | 02 | N | CABOZANTINIB | 101138085 |
| 10394092 | 10069071 | 1.76 | 94.9 | null | 2021-11-06 | 2022-01-30 | Capecitabine (21 day) + Irinotecan | 02 | null | CABOZANTINIB | 101218214 |